September 30, 2021 | CRISPR, Impetus Digital, Jessica Schwaber, Natalie Yeadon, Solupore, allogeneic therapies, cell engineering, cell therapy, gene therapy, gene-editing, non-viral modalities, precision medicine, viral modalities
Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing the full potential of cell & gene therapy, and much more.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
In the inaugural episode of Impetus Digital’s Leaders in Pharma podcast, I sit down with Samir Vattompadam. Samir is currently Vice President, Program Executive for EQRx.
Jeannie Chen, Head of Clinical Operations and People at Hazel Health, shares her insights on telemedicine and virtual care as means to improve healthcare access and equity among school-aged children….
Robert Niichel, Founder/CEO of SmartTab, explores the concept of personalized wireless drug delivery, including its advantages, barriers, and current status. We also discuss the future of digital medicine, the Internet…
Carol Stiff, Head of Canada at Santen, delves into what effective leadership looks like before, during, and after COVID-19; challenges brought on by the pandemic; the importance of developing partnerships…
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online.
Dr. José Morey, CEO and Founder of Ad Astra Media, Chief Medical Innovation Officer at Liberty BioSecurity, and the world’s first “intergalactic doctor” discusses AI, space medicine, human augmentation, and…
David Berg, President and CTO of Strainprint, explores the current state of the medical cannabis industry in Canada and overseas and how Strainprint is bringing innovation to the industry. He…
Jerome Madison, Host of The Precision Medicine Podcast, shares his leadership lessons and tips for building and training new sales teams in the era of precision medicine. He also dives…
Dr. Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. Among…
Julia Walsh, CEO of Brand Medicine International, explores the concept of “search listening” in healthcare, and how it can be used to inform brand strategy, improve patient-centricity, and fight scientific…
